ChainGen Bio Raises RMB 45M in Angel Round for X-oligo Conjugates Development
ChainGen Bio, a Shanghai-based developer of X-oligo conjugates (XOCs), has reportedly raised RMB 45 million...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity